Rifabutin
- Product NDC
- 70954-041
- 11-digit product format
- 709540041
- Labeler code
- 70954
- Product ID
- 70954-041_cc04157f-1cc1-4f4a-a77f-9042a99e7825
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rifabutin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- ANI Pharmaceuticals, Inc.
- Application
- ANDA215041
- Marketing category
- ANDA
- Marketing start
- 2021-12-17
- Substance
- RIFABUTIN
- Active strength
- 150 mg/1
- Pharmacologic classes
- Rifamycin Antimycobacterial [EPC], Rifamycins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Rifabutin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RIFABUTIN | 150 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 1W306TDA6S |
| Rxcui | 198200 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70954-041-10 | Rifabutin | 100 in 1 BOTTLE | CAPSULE | 100 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70954-041 | RIFABUTIN CAPSULE [ANI PHARMACEUTICALS, INC.] | 2 | Current NDC, Legacy NDC, 1 package rows | 20250410_baf8ec98-bd0c-4b87-a7ee-813335431b89.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70954-041-10 | 70954004110 | 100 CAPSULE in 1 BOTTLE (70954-041-10) | 100 capsule | 2021-12-17 | 0000-00-00 | No | No | Current |